美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=FENOFIBRIC ACID
符合检索条件的记录共10
1 页 当前第 1 页  返回检索页
1药品名称FENOFIBRIC ACID
申请号200264产品号001
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 45MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2016/09/07申请机构IMPAX LABORATORIES INC
2药品名称FENOFIBRIC ACID
申请号200264产品号002
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 135MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2016/09/07申请机构IMPAX LABORATORIES INC
3药品名称FENOFIBRIC ACID
申请号200750产品号001
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 45MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2013/12/04申请机构LUPIN LTD
4药品名称FENOFIBRIC ACID
申请号200750产品号002
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 135MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2013/12/04申请机构LUPIN LTD
5药品名称FENOFIBRIC ACID
申请号200913产品号001
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 45MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2013/03/25申请机构MYLAN PHARMACEUTICALS INC
6药品名称FENOFIBRIC ACID
申请号200913产品号002
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 135MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2013/03/25申请机构MYLAN PHARMACEUTICALS INC
7药品名称FENOFIBRIC ACID
申请号200920产品号001
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 45MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2015/10/07申请机构ACTAVIS ELIZABETH LLC
8药品名称FENOFIBRIC ACID
申请号200920产品号002
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 135MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2015/10/07申请机构ACTAVIS ELIZABETH LLC
9药品名称FENOFIBRIC ACID
申请号201573产品号001
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 135MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2013/07/18申请机构ANCHEN PHARMACEUTICALS INC
10药品名称FENOFIBRIC ACID
申请号201573产品号002
活性成分CHOLINE FENOFIBRATE市场状态处方药
剂型或给药途径CAPSULE, DELAYED RELEASE;ORAL规格EQ 45MG FENOFIBRIC ACID
治疗等效代码AB参比药物
批准日期2013/07/18申请机构ANCHEN PHARMACEUTICALS INC